- Home
- / Cardiovascular Systems
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Cardiovascular Systems financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$20
2023-05-02
Market Capitalization
$844 M
2023-05-02
Revenue
$236.2 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|
| Revenue | 236.5M | 259.0M | 236.2M |
| Cost of goods sold | 48.8M | 61.1M | 63.4M |
| Gross profit | 187.8M | 197.8M | 172.8M |
| Gross profit margin, % | 79.4% | 76.4% | 73.1% |
| General and administrative expense | 170.0M | 167.5M | 170.5M |
| Operating expense total | 214.6M | 209.8M | 208.6M |
| Depreciation and amortization | 1.2M | 1.2M | 1.3M |
| EBIT | (26.8M) | (11.9M) | (35.8M) |
| EBIT margin, % | -11.3% | -4.6% | -15.2% |
| Interest income | 1.7M | 499.0K | 817.0K |
| Interest expense | 2.0M | 1.7M | 1.6M |
| Pre tax profit | (27.0M) | (13.2M) | (36.6M) |
| Income tax expense | 231.0K | 252.0K | 310.0K |
| Net Income | (27.2M) | (13.4M) | (36.9M) |
| EPS | (0.8) | (0.3) | (0.9) |